The global branched stent grafts market is witnessing significant growth due to the increasing prevalence of aortic aneurysms, rising adoption of minimally invasive vascular procedures, and continuous advancements in endovascular technologies. The global branched stent grafts market size was valued at USD 376.28 million in 2025 and is projected to grow from USD 405.26 million in 2026 to USD 733.59 million by 2034, registering a CAGR of 7.7% during the forecast period (2026–2034).

Branched stent grafts have become an important treatment option for complex aortic aneurysms involving branch arteries. These devices help preserve blood flow to vital organs while providing a less invasive alternative to open surgical repair. Increasing awareness among healthcare providers, improvements in imaging technologies, and the growing availability of advanced endovascular devices are supporting the expansion of the global market.

Market Drivers

One of the primary factors driving the branched stent grafts market is the increasing prevalence of abdominal and thoracoabdominal aortic aneurysms. The rising geriatric population, growing incidence of hypertension, smoking-related vascular diseases, and other cardiovascular disorders are increasing the number of patients requiring advanced endovascular treatment.

Another major growth driver is the growing preference for minimally invasive procedures. Branched stent grafts enable physicians to treat complex aneurysms with smaller incisions, reduced blood loss, shorter hospital stays, and faster patient recovery compared to conventional open surgery. These clinical advantages are encouraging greater adoption across hospitals and specialty vascular centers.

Technological advancements in stent graft design are also contributing to market growth. Manufacturers are introducing customized branched devices with improved flexibility, enhanced durability, and better anatomical compatibility, allowing physicians to treat increasingly complex vascular conditions with greater precision.

Furthermore, rising healthcare expenditure, expanding vascular surgery programs, and growing investments in advanced cardiovascular care infrastructure are creating new opportunities for market participants worldwide.

Market Challenges

Despite favorable growth prospects, the branched stent grafts market faces several challenges.

One of the major restraints is the high cost of branched stent graft procedures and devices, which may limit accessibility in low- and middle-income countries.

Another challenge is the requirement for highly skilled vascular surgeons and specialized healthcare facilities to perform these complex endovascular procedures. Limited availability of trained professionals can restrict market growth in certain regions.

Additionally, stringent regulatory approval processes for cardiovascular medical devices and the potential risk of procedural complications may delay product commercialization and adoption.

Market Segmentation

By Product

• Thoracoabdominal Aortic Branched Stent Grafts
• Aortic Branched Stent Grafts
• Others

The thoracoabdominal aortic branched stent grafts segment holds a significant market share due to the increasing number of complex thoracoabdominal aneurysm repair procedures and ongoing advancements in device technology.

By End User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

The hospitals segment accounts for the largest market share owing to the availability of advanced imaging systems, hybrid operating rooms, experienced vascular specialists, and comprehensive postoperative care facilities required for complex endovascular procedures.

Regional Insights

North America

North America dominates the global branched stent grafts market due to its advanced healthcare infrastructure, high adoption of minimally invasive vascular procedures, strong reimbursement framework, and the presence of leading medical device manufacturers. The United States continues to account for the largest share of regional revenue.

Europe

Europe represents a significant market driven by increasing awareness of endovascular aneurysm repair, favorable healthcare policies, and growing investments in cardiovascular treatment technologies. Countries such as Germany, France, and the United Kingdom continue to contribute substantially to regional growth.

Asia-Pacific

Asia-Pacific is expected to witness the fastest growth during the forecast period owing to expanding healthcare infrastructure, increasing cardiovascular disease burden, rising healthcare expenditure, and growing adoption of advanced vascular treatment technologies across China, India, Japan, South Korea, and Southeast Asian countries.

Latin America, Middle East, and Africa

These regions are emerging markets supported by improving access to specialized cardiovascular care, increasing investments in hospital infrastructure, and growing awareness regarding minimally invasive treatment options for aortic aneurysms.

Key Players Analysis

The branched stent grafts market is highly competitive, with leading manufacturers focusing on product innovation, customized stent graft technologies, strategic partnerships, and regulatory approvals to strengthen their market presence. Companies continue investing in research and development to improve device performance, procedural safety, and long-term clinical outcomes.

Major companies operating in the market include:

• Cook Medical
• W. L. Gore & Associates, Inc.
• Medtronic plc
• Endologix LLC
• Terumo Corporation
• MicroPort Scientific Corporation
• Lifetech Scientific Corporation
• Braile Biomédica
• Bentley Innomed GmbH
• JOTEC GmbH

These companies continue expanding their product portfolios, investing in next-generation endovascular technologies, and collaborating with healthcare providers to improve the treatment of complex aortic diseases.

For Detailed Insights, Visit:

https://straitsresearch.com/report/branched-stent-grafts-market

About Us

Straits Research is a leading market research and intelligence organization specializing in research, analytics, and advisory services. The company provides comprehensive market reports, industry insights, and strategic business intelligence across multiple industries, helping organizations identify growth opportunities and make informed business decisions.

Contact Us

Email: sales@straitsresearch.com

Tel: +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.)